Ignite Creation Date:
2024-05-06 @ 1:53 AM
Last Modification Date:
2024-10-26 @ 11:11 AM
Study NCT ID:
NCT01928940
Status:
COMPLETED
Last Update Posted:
2017-07-24
First Post:
2013-07-03
Brief Title:
Japan PhIII of GSK2118436 and GSK1120212 Combination in Subjects With BRAF V600EK Mutation Positive Advanced Solid Tumors Phase I Part or Cutaneous Melanoma Phase II Part
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline